In light of these observations, it will be of interest to investigate GFRAL and RET receptor signaling in the context of the cancer-induced bone microenvironment and microarchitectural remodeling, and targeting the GDF15/GFRAL/RET axis could potentially provide a therapeutic avenue for reducing PCa-mediated bone metastasis. This evidence concerns the gene GFRAL and cancer.